These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7755224)

  • 1. Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program.
    Shiffman ML; Kaplan GD; Brinkman-Kaplan V; Vickers FF
    Ann Intern Med; 1995 Jun; 122(12):899-905. PubMed ID: 7755224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight.
    Broomfield PH; Chopra R; Sheinbaum RC; Bonorris GG; Silverman A; Schoenfield LJ; Marks JW
    N Engl J Med; 1988 Dec; 319(24):1567-72. PubMed ID: 3200265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction.
    Mazzella G; Bazzoli F; Festi D; Ronchi M; Aldini R; Roda A; Grigolo B; Simoni P; Villanova N; Roda E
    Gastroenterology; 1991 Aug; 101(2):490-6. PubMed ID: 2065925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study.
    Wudel LJ; Wright JK; Debelak JP; Allos TM; Shyr Y; Chapman WC
    J Surg Res; 2002 Jan; 102(1):50-6. PubMed ID: 11792152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well).
    Festi D; Colecchia A; Orsini M; Sangermano A; Sottili S; Simoni P; Mazzella G; Villanova N; Bazzoli F; Lapenna D; Petroni ML; Pavesi S; Neri M; Roda E
    Int J Obes Relat Metab Disord; 1998 Jun; 22(6):592-600. PubMed ID: 9665682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss.
    Worobetz LJ; Inglis FG; Shaffer EA
    Am J Gastroenterol; 1993 Oct; 88(10):1705-10. PubMed ID: 8213711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial.
    Haal S; Guman MSS; Boerlage TCC; Acherman YIZ; de Brauw LM; Bruin S; de Castro SMM; van Hooft JE; van de Laar AWJM; Moes DE; Schouten M; Schouten R; van Soest EJ; van Veen RN; de Vries CEE; Fockens P; Dijkgraaf MGW; Gerdes VEA; Voermans RP
    Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):993-1001. PubMed ID: 34715031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss.
    Sugerman HJ; Brewer WH; Shiffman ML; Brolin RE; Fobi MA; Linner JH; MacDonald KG; MacGregor AM; Martin LF; Oram-Smith JC
    Am J Surg; 1995 Jan; 169(1):91-6; discussion 96-7. PubMed ID: 7818005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of fiber administration in the prevention of gallstones in obese patients on a reducing diet. A clinical trial].
    Morán S; Uribe M; Prado ME; de la Mora G; Muñoz RM; Pérez MF; Milke P; Blancas JM; Dehesa M
    Rev Gastroenterol Mex; 1997; 62(4):266-72. PubMed ID: 9580234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination therapy with simvastatin and ursodeoxycholic acid is more effective for cholesterol gallstone dissolution than is ursodeoxycholic acid monotherapy.
    Tazuma S; Kajiyama G; Mizuno T; Yamashita G; Miura H; Kajihara T; Hattori Y; Miyake H; Nishioka T; Hyogo H; Sunami Y; Yasumiba S; Ochi H; Matsumoto T; Abe A; Adachi K; Omata F; Ueno F; Sugata F; Ohguri S; Shibata H; Kokubu S
    J Clin Gastroenterol; 1998 Jun; 26(4):287-91. PubMed ID: 9649013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones.
    Jüngst C; Sreejayan N; Zündt B; Müller I; Spelsberg FW; Hüttl TP; Kullak-Ublick GA; del Pozo R; Jüngst D; von Ritter C
    Eur J Clin Invest; 2008 Sep; 38(9):634-9. PubMed ID: 18837739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ursodiol or ibuprofen on contraction of gallbladder and bile among obese patients during weight loss.
    Marks JW; Bonorris GG; Schoenfield LJ
    Dig Dis Sci; 1996 Feb; 41(2):242-9. PubMed ID: 8601365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions of obesity and weight loss to gallstone disease.
    Everhart JE
    Ann Intern Med; 1993 Nov; 119(10):1029-35. PubMed ID: 8214980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of combined treatment with pravastatin and ursodeoxycholic acid on hepatic cholesterol metabolism.
    Hillebrant CG; Nyberg B; Gustafsson U; Sahlin S; Björkhem I; Rudling M; Einarsson C
    Eur J Clin Invest; 2002 Jul; 32(7):528-34. PubMed ID: 12153554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease. A double-blind, placebo-controlled trial.
    Méndez-Sánchez N; González V; Chávez-Tapia N; Ramos MH; Uribe M
    Ann Hepatol; 2004; 3(3):108-12. PubMed ID: 15505596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Ursodeoxycholic Acid for the Prevention of Gallstone Formation After Gastrectomy in Patients With Gastric Cancer: The PEGASUS-D Randomized Clinical Trial.
    Lee SH; Jang DK; Yoo MW; Hwang SH; Ryu SY; Kwon OK; Hur H; Man Yoon H; Eom BW; Ahn HS; Son T; Song KY; Lee HH; Choi MG; An JY; Lee SI; Lee KH; Ahn S; Park YS; Park DJ;
    JAMA Surg; 2020 Aug; 155(8):703-711. PubMed ID: 32584935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of cholesterol between vesicles and micelles in human gallbladder bile: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid.
    Sahlin S; Thyberg P; Ahlberg J; Angelin B; Einarsson K
    Hepatology; 1991 Jan; 13(1):104-10. PubMed ID: 1988332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and risk of gallstone development on a 1200 kcal/d (5025 Kj/d) regular food diet.
    Heshka S; Spitz A; Nuñez C; Fittante AM; Heymsfield SB; Pi-Sunyer FX
    Int J Obes Relat Metab Disord; 1996 May; 20(5):450-4. PubMed ID: 8696424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial.
    Miller K; Hell E; Lang B; Lengauer E
    Ann Surg; 2003 Nov; 238(5):697-702. PubMed ID: 14578732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of gallbladder emptying in gallstone formation during diet-induced rapid weight loss.
    Gebhard RL; Prigge WF; Ansel HJ; Schlasner L; Ketover SR; Sande D; Holtmeier K; Peterson FJ
    Hepatology; 1996 Sep; 24(3):544-8. PubMed ID: 8781321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.